Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology.
52W Range
22ndpctl
Volume
0.89×avg
Market Cap
652.03MUSD
P/E Ratio
-3.3TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Prime Medicine, Inc.
PRMENASDAQ Global Market·USD·Closed
Prime Medicine, Inc.
PRMENASDAQ·USD·Closed
$3.61
−0.82%
$3.61
−$0.03 (0.82%)
52W Range
22ndpctl
Volume
0.89×avg
Mkt Cap
652.03MUSD
P/E
-3.3TTM
Div Yield
–ann
PRME: Prime Medicine, Inc. Stock Analysis | finqOS
